Noble, an Aptar Pharma company, announced today that Drew Mellan has joined the team as director of account management. In this new position, Mellan will serve as the voice of the customer, communicating their goals and interests to Noble with the purpose of maximizing value for them.
Mellan has two decades of business development experience working with global pharmaceutical, industrial packaging, personal care and luxury fragrance companies. Most recently, he worked at Aptar Pharma, beginning in 2010 as a senior account manager where he successfully developed the company’s Consumer Health Care (CHC) business in North America. In 2015, he joined the Aptar GSK Global Account team. Under his guidance, GSK and Aptar Pharma partnered to launch the highly successful transition of Flonase from a prescription to an over-the-counter drug therapy, considered the “gold standard switch” by GSK and the industry.
Prior to joining Aptar Pharma, Mellan held business development management positions in the packaging industry with companies such as Sonoco Products Company, the world’s largest producer of composite cans, tubes and cores; and Qualipac America, a developer of packaging for the luxury beauty industry.
“This is a unique position for our business development team; one that places emphasis on building personal relationships to meet the needs of our existing clients and maximize our value to them,” explained Noble CEO Jeff Baker. “Drew’s overarching role is to understand and communicate our customers’ goals and interests so that Noble can leverage our expertise and best practices and identify products and core services that address their challenges.”
Mellan holds a Bachelor of Science in Finance from Rowan University in New Jersey.